Ind-Swift Laboratories Ltd. (ISLL) is a USD ^~ 200 million, fast growing active pharmaceutical ingredient (API) and contract research and manufacturing services (CRAMS) company, based in Chandigarh, North India.
ISLL was established in 1995 and is listed on Mumbai and Luxemburg stock exchanges.
ISLL's commercial manufacturing facility at Derabassi, Punjab has FDA, EDQM, TGA, PMDA, KFDA and other approvals, 19 manufacturing blocks including a High Potent API plant and a hydrogenation plant and a fully-equipped cGMP pilot plant.
The other manufacturing units are GMP / nonGMP, for early and advanced intermediates.
ISLL has gained substantial expertise in successfully handling a breadth of chemistries and reagents at lab, pilot and manufacturing scale.

ISLL–CRAMS offers world class services across early phase drug development, process R&D, contract manufacturing to analytical and regulatory services. The CRAMS business is managed by proactive, flexible and customer-centric team of experienced scientific and commercial professionals.

We have successful track record of cost efficient and on time delivery of projects.

We take pride in our rapid responsiveness and execution excellence, leading to "Customer Delight"